Source:http://linkedlifedata.com/resource/pubmed/id/18382208
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-4-2
|
pubmed:abstractText |
There is considerable increase in the use of left ventricular assist devices for the treatment of severe heart failure. Traditionally viewed as a bridge to transplantation and more recently as a destination therapy, left ventricular assist device support is now recognized to offer potential for myocardial recovery through reverse remodeling, a potential that is further enhanced by combination with pharmacologic therapy. In this study, we examine the molecular changes associated with left ventricular assist device support and how these may contribute to the recovery process.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0268-4705
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
206-18
|
pubmed:meshHeading |
pubmed-meshheading:18382208-Animals,
pubmed-meshheading:18382208-Heart Failure,
pubmed-meshheading:18382208-Heart-Assist Devices,
pubmed-meshheading:18382208-Humans,
pubmed-meshheading:18382208-Myocytes, Cardiac,
pubmed-meshheading:18382208-Signal Transduction,
pubmed-meshheading:18382208-Ventricular Remodeling
|
pubmed:year |
2008
|
pubmed:articleTitle |
Left ventricular assist device-induced molecular changes in the failing myocardium.
|
pubmed:affiliation |
Imperial College London, NHLI, Heart Science Centre, Harefield Hospital, Harefield, UK.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|